Brian Silver's most recent trade in Tscan Therapeutics Inc was a trade of 632,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tscan Therapeutics Inc | Brian Silver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 632,500 | 632,500 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.56 per share. | 27 Dec 2022 | 3,158 | 32,885 | - | 1.6 | 4,941 | Voting Common Stock |
| Tscan Therapeutics Inc | Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 27 Dec 2022 | 2,842 | 29,727 | - | 1.5 | 4,276 | Voting Common Stock |
| Tscan Therapeutics Inc | Brian Silver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.40 per share. | 24 Mar 2022 | 15,000 | 26,885 | - | 3.4 | 50,982 | Voting Common Stock |
| Tscan Therapeutics Inc | Brian Silver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 6.32 per share. | 21 Sep 2021 | 5,000 | 11,885 | - | 6.3 | 31,585 | Voting Common Stock |
| Tscan Therapeutics Inc | Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.48 per share. | 09 Sep 2021 | 5,885 | 6,885 | - | 8.5 | 49,925 | Voting Common Stock |
| Tscan Therapeutics Inc | Brian Silver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 250,441 | 250,441 | - | - | Stock Option (right to buy) | |
| Tscan Therapeutics Inc | Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 15 Jul 2021 | 1,000 | 1,000 | - | 15 | 15,000 | Voting Common Stock |